salsolinol has been researched along with Neurodegenerative Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Copeland, RL; Csoka, AB; Getachew, B; Manaye, KF; Tizabi, Y | 1 |
| Bugajski, A; Gajda, M; Gil, K; Kurnik, M; Thor, P | 1 |
2 other study(ies) available for salsolinol and Neurodegenerative Diseases
| Article | Year |
|---|---|
Dihydromyricetin Protects Against Salsolinol-Induced Toxicity in Dopaminergic Cell Line: Implication for Parkinson's Disease.
Topics: Cell Line, Tumor; Dopamine; Dopaminergic Neurons; gamma-Aminobutyric Acid; Humans; Neuroblastoma; Neurodegenerative Diseases; Neuroprotective Agents; Parkinson Disease | 2023 |
Neuropathic alterations of the myenteric plexus neurons following subacute intraperitoneal administration of salsolinol.
Topics: alpha-Synuclein; Animals; Apoptosis; bcl-2-Associated X Protein; Choline O-Acetyltransferase; Injections, Intraperitoneal; Intestinal Pseudo-Obstruction; Isoquinolines; Male; Myenteric Plexus; Neurodegenerative Diseases; Neurons; Nitric Oxide Synthase; Rats; Rats, Wistar; Ubiquitin Thiolesterase | 2015 |